相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Elevated Clozapine Concentrations in Clozapine-Treated Patients with Hypersalivation
Georgios Schoretsanitis et al.
CLINICAL PHARMACOKINETICS (2021)
Antipsychotic medication exposure, clozapine, and pneumonia: results from a self-controlled study
C. Rohde et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
Systematic review and meta-analysis of rates of clozapine-associated myocarditis and cardiomyopathy
Dan Siskind et al.
AUSTRALIAN AND NEW ZEALAND JOURNAL OF PSYCHIATRY (2020)
Around 3% of 1,300 Levels Were Elevated during Infections in a Retrospective Review of 131 Beijing Hospital In-Patients with More than 24,000 Days of Clozapine Treatment
Can-Jun Ruan et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Pneumonia may be more frequent and have more fatal outcomes with clozapine than with other second-generation antipsychotics
Jose de Leon et al.
WORLD PSYCHIATRY (2020)
Pneumonia risk: approximately one-third is due to clozapine and two-thirds is due to treatment-resistant schizophrenia
A. G. Villasante-Tezanos et al.
ACTA PSYCHIATRICA SCANDINAVICA (2020)
A Rational Use of Clozapine Based on Adverse Drug Reactions, Pharmacokinetics, and Clinical Pharmacopsychology
Jose de Leon et al.
PSYCHOTHERAPY AND PSYCHOSOMATICS (2020)
Clozapine is strongly associated with the risk of pneumonia and inflammation
Jose de Leon et al.
GENERAL PSYCHIATRY (2020)
A comprehensive review of swallowing difficulties and dysphagia associated with antipsychotics in adults
Giuseppe Cicala et al.
EXPERT REVIEW OF CLINICAL PHARMACOLOGY (2019)
Effect of tobacco smoking on the risk of developing community acquired pneumonia: A systematic review and meta-analysis
Vadsala Baskaran et al.
PLOS ONE (2019)
Clinical determinants of fever in clozapine users and implications for treatment management: A narrative review
Helene Verdoux et al.
SCHIZOPHRENIA RESEARCH (2019)
Patient characteristics, burden and pharmacotherapy of treatment-resistant schizophrenia: results from a survey of 204 US psychiatrists
Christoph U. Correll et al.
BMC PSYCHIATRY (2019)
Estimating the Risk of Pneumonia in Patients With Schizophrenia Newly Receiving Clozapine A Nationwide Cohort Study
Chi-Shin Wu et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2019)
The Effect of Body Weight Changes on Total Plasma Clozapine Concentrations Determined by Applying a Statistical Model to the Data From a Double-Blind Trial
Francisco J. Diaz et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2018)
Benzodiazepines and risk of pneumonia in schizophrenia: a nationwide case-control study
Sheng-Yun Cheng et al.
PSYCHOPHARMACOLOGY (2018)
Adverse cardiac events in out-patients initiating clozapine treatment: a nationwide register-based study
C. Rohde et al.
ACTA PSYCHIATRICA SCANDINAVICA (2018)
International trends in clozapine use: a study in 17 countries
C. J. Bachmann et al.
ACTA PSYCHIATRICA SCANDINAVICA (2017)
Assessing drug-drug interactions through therapeutic drug monitoring when administering oral second-generation antipsychotics
Edoardo Spina et al.
EXPERT OPINION ON DRUG METABOLISM & TOXICOLOGY (2016)
The incidence and all-cause mortality of pneumonia in patients with schizophrenia: A nine-year follow-up study
Frank Huang-Chih Chou et al.
JOURNAL OF PSYCHIATRIC RESEARCH (2013)
Body mass index and risk of pneumonia: a systematic review and meta-analysis
D. T. Phung et al.
OBESITY REVIEWS (2013)
Cardiac Complications Associated with Short-Term Mortality in Schizophrenia Patients Hospitalized for Pneumonia: A Nationwide Case-Control Study
Ya-Tang Liao et al.
PLOS ONE (2013)
Second-Generation Antipsychotic Medications and Risk of Pneumonia in Schizophrenia
Chian-Jue Kuo et al.
SCHIZOPHRENIA BULLETIN (2013)
Antipsychotic drug use and risk of pneumonia in elderly people
Wilma Knol et al.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY (2008)
Serious adverse drug events reported to the food and drug administration, 1998-2005
Thomas J. Moore et al.
ARCHIVES OF INTERNAL MEDICINE (2007)
Weight gain during a double-blind multiclosage clozapine study
Jose de Leon et al.
JOURNAL OF CLINICAL PSYCHOPHARMACOLOGY (2007)
A meta-analysis of worldwide studies demonstrates an association between schizophrenia and tobacco smoking behaviors
J de Leon et al.
SCHIZOPHRENIA RESEARCH (2005)
Time response of cytochrome P450 1A2 activity on cessation of heavy smoking
MS Faber et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2004)
分享论文
